Background-Among intermediate-to high-risk patients with chest pain, we have shown that a cardiac magnetic resonance (CMR) stress test strategy implemented in an observation unit (OU) reduces 1-year health care costs compared with inpatient care. In this study, we compare 2 OU strategies to determine among lower-risk patients if a mandatory CMR stress test strategy was more effective than a physicians' ability to select a stress test modality. Methods and Results-On emergency department arrival and referral to the OU for management of low-to intermediate-risk chest pain, 120 individuals were randomly assigned to receive (1) a CMR stress imaging test (nϭ60) or (2) 
R ecent investigations of stress cardiac magnetic resonance (CMR) in patients with acute chest pain have demonstrated high accuracy for acute coronary syndrome (ACS) and established the ability of CMR to diagnose recent infarction, detect inducible ischemia, and predict 1-year prognosis in patients presenting to the emergency department (ED). 1,2 A previous clinical trial among patients with chest pain at intermediate or high-risk for ACS demonstrated that CMR imaging combined with observation unit (OU) care reduces cost at 1 year without a difference in outcomes compared with inpatient management. 3, 4 However, most commonly lowerrisk patients are treated in OUs, where they have been shown to decrease the cost of care and are associated with low rates of short-term ACS after discharge. [5] [6] [7] In lower-risk patients receiving care in an OU, it is unclear whether a mandatory CMR stress imaging strategy would be more effective than the current OU strategy whereby care providers choose among various stress imaging strategies.
Clinical Perspective on p 118
The objective of this clinical trial was to determine the relevant comparison of a mandatory stress CMR versus a provider determined stress testing strategy (provider choice or PC) in an OU setting in patients with lower-risk chest pain.
To assess this objective, we compared these two imaging strategies primarily on efficiency, measured as length of stay, and secondarily on cost and efficacy, measured as cardiac catheterizations without coronary intervention, appropriateness of cardiovascular admission decisions, and clinical outcomes.
Methods

Study Design
We performed a single-center, randomized, clinical trial. After approval by the institutional review board of Wake Forest School of Medicine and obtaining extramural funding, all participants provided written informed consent. The trial was registered on clinicaltrials-.gov (NCT00869245) before participant recruitment. The trial was distinct from a previously reported clinical trial, 3, 4 and both trials did not enroll simultaneously.
Study Setting and Population
The study population consisted of patients presenting to the ED of the Wake Forest Baptist Medical Center with acute chest pain or related symptoms concerning for ACS. Eligibility criteria were designed to enroll participants representative of those commonly treated in US chest pain observation units at low to intermediate risk for ACS, excluding those at very high or very low risk for ACS.
The risk assessment for eligibility required that the patient have either a Thrombolysis In Myocardial Infarction (TIMI) 8 risk scoreՆ1 or a physician impression that the participant exhibited an intermediate likelihood of ACS. The risk assessment also included care provider assessments that the patient required an inpatient or OU evaluation for their chest pain, that coronary arteriogram (either by invasive angiography or CT angiography) was not indicated at the time of enrollment, and that the patient was safe for OU care. Patients with multiple prior stents, multiple prior MIs, or percutaneous coronary intervention(PCI)/coronary artery bypass graft in the past 6 months were not considered safe for OU care.
Additional eligibility criteria included age Ն18 years; patients were ineligible for enrollment if they exhibited an initial elevation of troponin I above the decision threshold (Ͼ 1.0 ng/mL), new ST-segment elevation or depression, contraindications to CMR, inability to lie flat, hypotension (systolic blood pressure Ͻ90 mm Hg), renal insufficiency (estimated glomerular filtration rate Ͻ45 mL/min), life expectancy Ͻ3 months, pregnancy, solid organ transplant, chronic liver disease, or refused medical record review and follow-up at 30 days.
Randomization
Randomization was stratified to ensure equal distribution of key covariates thought to be related to length of stay; these measures were time of ED presentation (6 AM to 3 PM or 3 PM to 6 AM) and established coronary disease (yes or no). To ensure equal accrual among study groups within the 4 strata, a blocked randomization sequence of randomly varying size (2, 4, or 6) was created. The randomization sequences were generated using SAS v9.1 (SAS Institute Inc, Cary, NC) and given to a staff member not involved in participant recruitment. This staff member assigned each randomization sequence to 1 of the 4 strata and used this sequence to create bins of numbered, sealed, opaque envelopes.
Study Groups
Participants were randomly assigned to receive OU care with either stress CMR imaging (OUCMR) or provider choice (PC) care whereby imaging was determined by the care provider. All participants had orders placed for serial cardiac markers and ECGs at 0 hours, 4 hours, and 8 hours from ED arrival. Before conducting stress imaging, patients with acute MI were detected with serial cardiac markers or resting CMR imaging as described below. Patients with ongoing ischemic symptoms including resting angina were treated in the coronary care unit and not eligible for this study.
Noninvasive imaging was conducted during the index visit as per standard care at the study institution. Noninvasive imaging options available included stress (pharmacological or exercise) echocardiography, stress nuclear imaging, stress CMR, and coronary CT angiography (CCTA). According to previously published techniques, CCTA images with calcium scoring were obtained with a 64-slice LightSpeed VCT (GE Health Care, Milwaukee, WI). 9 Nuclear imaging was performed using single-photon emission computed tomography with rest and stress injections of technetium 99m-tetrofosmin (Myoview, GE Health Care). Stress echocardiography was performed with either treadmill or dobutamine stress in a laboratory accredited by the Intersocietal Commission for the Accreditation of Echocardiography Laboratories. All imaging modalities are available from 8 AM to 5 PM weekdays. After random assignment, care was determined by the care providers. Cardiology consultations were available in both arms, based on clinical need.
CMR Imaging Sequence
CMR imaging was conducted using vasodilator (adenosine) stress unless contraindicated, in which case dobutamine stress was performed. Rest imaging and visualization of the thoracic aorta and proximal pulmonary arteries through the second bifurcation were conducted before stress imaging. Imaging sequences included resting wall motion, T2-weighted imaging to assess for myocardial edema, stress perfusion, rest perfusion, and delayed enhancement ( Table 1) . Imaging interpretation was performed by board-certified radiology and cardiology faculty with at least level 2 training in CMR. 10 
Participant Follow-Up and Outcomes
Participants underwent a structured record review and a telephone interview, using a structured script at 30 days to determine outcomes. Additional information on data handling is available in the onlineonly Data Supplement Materials.
The primary outcome was length of stay, defined as the difference between the time of ED arrival and discharge from the hospital. Secondary outcomes included the appropriateness of the observation unit disposition decision and cardiac catheterizations not leading to coronary intervention (nontherapeutic cardiac catheterizations). The appropriateness of disposition decisions has been previously used to determine the impact of imaging on chest pain triage. 11 Correct dispositions were considered patients discharged home without an ACS event at 30 days or admitted and having an ACS event within 30 days.
The outcomes of ACS and MI were adjudicated by 2 boardcertified emergency physicians blinded to the patient's study group. ACS was defined as acute MI, ischemia symptoms leading to revascularization, death probably related to cardiac ischemia, or a discharge diagnosis of definite or probable unstable angina with evidence of coronary stenosis Ͼ70% or inducible ischemia on stress testing in subjects not undergoing cardiac catheterization. Diagnosis of acute MI included either autopsy findings of acute MI or a typical rise and fall of troponin I (Ͼ1.0 ng/dL) with 1 of the following: ischemic symptoms, development of pathological Q waves, STsegment elevation or depression, or coronary artery intervention. Troponin I assays during the study period were the TnI-Ultra (ADVIA Centaur platform, Siemens) or the Access AccuTnITroponin I (dxi800s platform, Beckman Coulter).
The cost of the index hospital visit was calculated on the basis of individual patient charges, as previously described by this study team. 3 For all payers, itemized hospital charges from each participant were converted to cost using departmental-specific cost-to-charge ratios used to file reports with Centers for Medicare and Medicaid Services annually. Provider charges were converted to cost by calculating work-related relative value units for services provided and then converting these to cost by using the Medicare conversion factor.
The sample size for this trial was chosen to provide adequate power to detect a difference in length of stay, the primary outcome of this trial. A model was constructed using preliminary data for lengths of stay, estimating the number of patients in each arm able to undergo same-day imaging, and accounting for the accuracy of the imaging modalities. This model suggested a 7.8-hour reduction in length of stay might be associated with CMR testing. Standard deviation for length of stay was estimated at 13.0 hours, based on the first 10 participants receiving OUCMR care in a previous study. 3 Using this information, we calculated that 120 patients would provide 90% power with a 2-sided ␣ of 0.05, using linear regression to detect a 7.8-hour difference in mean length of stay.
Data Analysis
All analyses were conducted using SAS v9.2 (SAS Institute, Cary, NC). Data were examined to assess distributions of outcome variables and key covariates. Presenting characteristics, raw length of stay intervals, cost, proportion of correct dispositions, and nontherapeutic cardiac catheterizations of the study groups were examined using 2 and Fisher exact tests for proportions, t tests for normally distributed continuous variables, and Kruskal-Wallis tests for nonnormal continuous variables, based on intention to treat. The outcome variables length of stay and cost were found to have skewed distributions. These variables were modeled using the log transform in PROC MIXED, adjusting for the 2 randomization strata, demographics and presenting characteristics.
Results
Over 18 months of screening, 270 patients were approached; of these, 73 met exclusion criteria, 74 declined participation, and 123 consented to participate and were randomly assigned ( Figure 1 ). Common reasons for exclusion were contraindications to MRI (nϭ26) and not suitable for observation unit care (nϭ13). Soon after random assignment, 3 participants were found to have exclusions (liver disease, nϭ2) or physician determination that the patient was not safe for OU care (nϭ1) representing protocol deviations. Due to safety concerns, these participants were withdrawn from the study protocol before any study interventions and excluded from analysis. One additional protocol deviation occurred due to the care provider's intent to order a coronary CT. This was not a safety concern; the participant was not withdrawn from the study protocol and was included in the analysis.
Randomization groups did not differ in terms of all baseline characteristics of interest (Tables 2 and 3 ). The mean age of participants was 53Ϯ11 years, with 15% Ͼ65 years in age. Prior MI was confirmed in 4% of participants, and a previous diagnosis of heart failure was confirmed in 3%. Cardiac testing performed is shown in Table 4 . In the CMR group, all participants had an initial order placed for stress CMR; 10 (17%) participants did not receive CMR due to anxiety/claustrophobia (nϭ2), unable to receive stress agents (nϭ2), scanner out of service (nϭ2), admission required for increasing troponin (nϭ1), or another indication for hospital admission developed (nϭ3).
Efficiency
Length of stay (LOS) was not statistically different between the study groups. In the CMR group, the median LOS was 24.2 hours compared with 23.8 hours in the PC group (Pϭ0.75, Kruskal-Wallis). LOS was not normally distributed and therefore was log-transformed for linear regression modeling. After accounting for the 2 randomization strata, no additional covariates significantly contributed to the model. In the final model containing study group and the 2 stratification variables, there was no significant difference in LOS among groups (Pϭ0.75, F test from analysis of covariance). These findings did not differ when excluding PC participants undergoing CMR testing as the first test (Pϭ0.80). LOS intervals by study group are shown in Figure 2 . Subgroup comparisons for LOS are shown in online-only Data Supplement Table 1 .
The mean costs of the index visit were $2586 for the CMR group and $2050 for the PC group; median costs were $2005 and $1686, respectively (Table 5) . Cost data were found to be rightward skewed. Significant differences among groups favoring a reduced cost for PC participants were seen when 1 comparing the log-transformed data using a t test (Pϭ0.007), 2 regression accounting for strata, age, race, ED impression, TIMI risk score, prior MI, and prior heart failure (Pϭ0.005), and 3 when comparing the distributions with a Kruskal-Wallis Test (PϽ0.001). Cost remained lower among PC participants when excluding PC participants undergoing CMR testing 
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from the regression analysis (PϽ0.001) and when removing the hospital noninvasive imaging cost from all participants' cost (Pϭ0.03, Fisher exact comparison of log-transformed data). Itemized costs are shown in Table 5 . CMR participants had higher pharmacy and noninvasive imaging cost. Among participants from both groups who received CMR testing, an average pharmacy cost increase of $136 was observed compared with those not undergoing CMR consistent with the additional cost from the pharmacological stress agent. Both groups had a very low incidence of nontherapeutic cardiac catheterizations (CMR, 0% versus 3%). Cardiac catheterizations during the index visit were performed in 3 patients in the PC group, 1 resulting in PCI. In the CMR group, 2 catheterizations were performed both resulting in PCI.
Clinical Outcomes
An adjudicated diagnosis of ACS occurred in 2 patients from each group within 30 days of random assignment. In the CMR group, both patients had ACS during the index visit (1 with PCI, 1 with MI and PCI). In the PC group, 1 patient had ACS during the index visit due to MI with PCI, and 1 patient had ACS after discharge due to MI.
Test Performance
Cardiac testing by study group is shown in Table 4 . In the CMR group, 57 of 60 participants had cardiac imaging with 2 tests positive for inducible ischemia or significant stenosis (Ն70%); both had an adjudicated diagnosis of ACS. In the PC group, 60 of 60 had cardiac imaging with 2 tests positive for inducible ischemia or significant stenosis; 1 had an adjudicated diagnosis of ACS. The initial imaging modality performed was nondiagnostic in 6 of 60 CMR participants and 4 of 60 PC participants. Among the 48 participants in 
Process of Care Delivery
Care providers made appropriate disposition decisions, based on the occurrence of ACS in 87% of CMR participants compared with 93% of PC participants (Pϭ0.36). In the CMR group, inappropriate disposition decisions involved 8 participants who were admitted after OU care and did not have ACS. Reasons for admission among these participants included to further evaluate for ACS (nϭ6) and treatment for pulmonary embolism (nϭ2). In the PC group, inappropriate disposition decisions were observed in 4 participants. These included 3 participants who were admitted to further evaluate for ACS and did not have ACS and 1 participant who was discharged and later found to have ACS. Cardiology consultations were obtained in 10 participants in the CMR group and 6 in the PC group (see online-only Data Supplement Materials for consultation reasons). Participants receiving cardiology consults had higher median cost ($2446 versus $1829, PϽ0.001) and longer median LOS (28.5 hours versus 23.7 hours, Pϭ0.02). Regression analysis of log-transformed data was used to adjust for consultations. After adjustment for consultations, OUCMR continued to have higher cost (Pϭ0.01) and similar LOS (Pϭ0.91).
Discussion
The results of this study indicate that the ability of a physician to determine the cardiac stress imaging modality among a range of options including echocardiography, radionuclide imaging, and CMR for lower-risk patients being treated in an OU is more effective than a mandatory CMR-based testing strategy. Increased effectiveness of the physician choice strategy was evidenced by similar LOS, similar outcomes, and lower cost. The design of this trial differs from our previous clinical trial in that the previous trial enrolled a higher-risk patient population and randomly assigned participants to inpatient care or OU care with CMR stress testing. In those more complex patients, CMR imaging allows expansion of OU care to higher-risk patients typically treated as inpatients without an increase in adverse events and while reducing cost 1 year from random assignment. 3, 4 In the current trial, we aimed to enroll a lower-risk population, typical of those treated in US OUs, and randomize to a mandatory CMR strategy versus a physician choice strategy consistent with usual care. Tables 2 and 5 display the relatively young mean age of participants in this trial, the low rate of prior cardiac events, and the low overall event rate. In Heart rate, beats/min* 81 (13) 79 ( these lower-risk patients, it appears the physician's ability to tailor testing to the individual patient, while considering institutional imaging strengths, may be a key to enhanced health care efficiency.
These findings convey an important message regarding efficient health care delivery. It has been suggested that variability in health care delivery is a driver of cost and inefficiency. 12 We have shown that eliminating this variability does not necessarily lead to a decrease in cost. Previously, it has been shown that patients are better suited for different imaging studies based on sex, body habitus, and so forth. As an example, CMR stress testing results are highly efficacious in patients not well suited for dobutamine stress echocardiography because of poor acoustic windows. 13 In the PC group in this study, providers carefully selected the patient's imaging modality. For instance, in PC participants with prior MI (a group that physicians may perceive to be a higher risk of ACS), all received CMR perfusion stress imaging with techniques that could discriminate old from new infarcts. While we did not survey our physicians to collect data regarding their test preferences, the results of this study support the notion that among lower risk OU patients, physician choice is an important component to efficient care delivery.
The cost increase in the OUCMR arm was driven by increased hospital-related cost. Hospital-related costs are shown in Table 5 and demonstrate increases among OUCMR participants in pharmacy and noninvasive imaging cost. Pharmacy cost includes the stress agent (adenosine, typical cost $170 to $243) and noninvasive imaging cost includes the contrast agent (gadobenate dimeglumine, typical cost $140 to $190) administered during the MR examination. PC participants undergoing exercise stress exams (46%) did not accumulate similar charges. The impact of stress and contrast agents on MRI stress costs may decrease as these agents become available generically.
An uncertain component to our analysis relates to the high number (12%) of relevant ancillary findings in the CMR group. These cases added complexity, probably increased cost, yet have potential for positive effects on long-term health. A larger study measuring both cost and effectiveness are required to determine if these findings are statistically more common in the CMR group and whether they lead to an improvement in health.
The design and implementation of this trial brought forth unique challenges relating to the integration of our study intervention (CMR) into usual care. For example, CMR was commonly selected for more complicated patients in the PC arm. While reflecting "real life" decision-making, this ultimately reduced the power to detect a difference in LOS. Excluding these participants would have introduced selection bias. Restricting these patients from undergoing CMR may not have been ethical. The institutional proficiency and adoption of cardiovascular imaging techniques must be considered when designing larger cardiovascular imaging trials. There are limitations to our findings. First, the trial was conducted at a single center with extensive experience in CMR and echocardiographic imaging. We are uncertain of results using other mandated imaging strategies with other modalities. Second, the PC comparison group received stress testing with multiple modalities. This variety is reflective of typical care patterns and is consistent with other OU publications. 6, 14 However, the design of this trial precludes a direct comparison of imaging modalities with one another. Third, the enrollment criteria required the care provider assessment that the patient was safe for OU care. Highly complicated patients were commonly rated as not being safe for OU care by the care providers. As a result, the study population reflects a population commonly managed in observation units in the United States but differs from the higher-risk population that we previously demonstrated to be safely treated in an OU setting with OUCMR. Finally, adjustment was not made for multiple statistical comparisons. It is possible that "positive" findings could be spurious in light of the large number of tests at the 0.05 significance level.
Conclusions
In patients with lower-risk chest pain receiving ED-directed OU care, the ability of a physician to select a cardiac stress imaging modality (including echocardiography, CMR, or radionuclide testing) was more cost effective than a pathway that mandates a CMR stress test. Contrary to prior observations in individuals with intermediate-to high-risk chest pain, in those with lower-risk chest pain, these results highlight the importance of physician-related choices during ACS diagnostic protocols. Comparison of log-transformed data with a Student t test.
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